What do they want?, page-25

Yes apart from what Boslo eluded to, my supposition is that there may be some difference in actual composition, sure the intrinsic molecule might be the same but it might be diluted or at least combined with other additives if it is to be given on a consistent weekly basis over a longer period of time (years!?)

I'm really only going by what I'm reading in terms of rough pricing. In actuality we will of course need to wait till for later stages to know what charges are possible.

There is certainly more of an overhead in administration of the said drug via IV. -v- SubQ, at least a 50% increase as a general rule:

"A cost analysis showed administration costs 50% lower in
the subcutaneous compared to infusion routes, with most patients administering
subcutaneous medicines themselves. Other indirect benefits to this route included
less pressure on infusion unit waiting times/reduced risk of COVID-19 infection plus
reduced patient ‘out of pocket’ costs. " <sup>1




REF
https://chesterrep.openrepository.com/bitstream/handle/10034/625183/ijcp.14341.pdf?sequence=2#:~:text=A%20cost%20analysis%20showed%20administration,patients%20administering%20subcutaneous%20medicines%20themselves.</sup>